Axsome Therapeutics Inc.
AXSM | NASDAQ
$136.01
-$8.42 (-5.83%)
At close: Nov 2, 2026, 4:00 PM ET
$137.00
-$7.43 (-5.14%)
Pre-market:
Nov 2, 2026, 9:28 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 319.85M | 305.11M | 322.93M | 325.27M | 303.02M | 300.91M | 315.35M | 327.34M | 315.66M | 331.44M | 386.19M | 416.56M | 437.11M | 246.52M | 200.84M | 227.52M | 73.39M | 84.71M | 86.47M | 114.62M | 141.22M | 164.66M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 35.45M | 31.4M | 27.4M | 23.09M | 24.25M | 20.61M | 18.53M | 16.07M | 16.26M | 11.89M | 11.03M | 14.12M | 15.26M | 15.52M | 14.72M | 12.4M | 507.46K | 322.91K | 322.91K | 322.91K | 317.37K | 317.38K |
Receivables | 277.46M | 251.06M | 224.46M | 196.51M | 198.83M | 161.4M | 142M | 124.1M | 120.34M | 101.43M | 94.82M | 78.42M | 67.41M | 44.79M | 37.7M | 20.3M | 16.17M | n/a | n/a | n/a | n/a | n/a |
Inventory | 37.88M | 31.52M | 27.94M | 23.77M | 18.44M | 16.32M | 15.73M | 14.27M | 15.22M | 15.58M | 15.14M | 9.99M | 9.25M | 7.94M | 4.32M | 2.1M | 10.32M | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 23.52M | 13.65M | 19.79M | 16.34M | 16.01M | 11.98M | 13.41M | 11.81M | 12.03M | 8.12M | 6.8M | 5.91M | 5.2M | 2.78M | n/a | 1 | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 656.57M | 611.21M | 588.99M | 565.34M | 536.62M | 494.63M | 485.06M | 479.11M | 463.03M | 460.49M | 504.26M | 511.76M | 519.69M | 304.45M | 245.64M | 252.38M | 103.98M | 86.83M | 86.52M | 115.02M | 141.65M | 165.04M |
Property-Plant & Equipment | 20.03M | 20.01M | 20.86M | 26.65M | 23.14M | 24.07M | 5.97M | 5.73M | 6.8M | 9.61M | 7.62M | 8.04M | 8.15M | 809K | 1.14M | 1.01M | 1.3M | 1.41M | 944.01K | 1.25M | 1.29M | 1.55M |
Goodwill & Intangibles | 49.4M | 50.99M | 52.56M | 54.17M | 55.78M | 57.36M | 58.94M | 60.54M | 62.15M | 63.74M | 65.33M | 66.94M | 68.54M | 68.4M | 69.97M | 73.16M | 74.77M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 104.88M | 102.4M | 100.82M | 103.91M | 103.17M | 102.04M | 83.43M | 82.35M | 85.2M | 85.24M | 83.97M | 89.09M | 91.95M | 84.73M | 85.83M | 86.57M | 76.58M | 1.73M | 1.27M | 1.57M | 1.61M | 1.87M |
Total Assets | 761.45M | 713.61M | 689.81M | 669.25M | 639.79M | 596.67M | 568.5M | 561.46M | 548.23M | 545.73M | 588.24M | 600.86M | 611.64M | 389.18M | 331.48M | 338.96M | 180.56M | 88.56M | 87.79M | 116.6M | 143.26M | 166.9M |
Account Payables | 78.97M | 106.7M | 65.54M | 54.23M | 91.63M | 85.66M | 72M | 64.25M | 61.34M | 53.79M | 40.68M | 29.1M | 42.96M | 35.77M | 38.61M | 12.84M | 19.43M | 12.6M | 13.15M | 13.38M | 11.61M | 14.62M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 492K | n/a | n/a | 65.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 70M | 70M | 72.98M | 70M | 70M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 11.2M | 38.17M | 203.28M | 37.49M | 30.36M | 28.2M | 36.51M | 27.5M | 7.04M | 71.86M | 26.86M | 6.67M | -3.6M | 13.27M | 17.18M | 41.39M | 9.82M | 2.01M | 4.05M | 3.06M | 3.03M | 1.17M |
Total Current Liabilities | 460.45M | 439.21M | 378.84M | 360.29M | 342.1M | 243.91M | 230.1M | 196.19M | 186.57M | 144.05M | 138.85M | 114.66M | 114.97M | 100.65M | 96.56M | 60.28M | 42.57M | 24.55M | 23.07M | 24.71M | 22.86M | 21.68M |
Long-Term Debt | 117.96M | 146.08M | 140.93M | 117.64M | 117.54M | 181.38M | 180.71M | 180M | 179.33M | 178.69M | 178.07M | 177.45M | 176.82M | 147.62M | 94.26M | 93.91M | 93.46M | 49.31M | 49.09M | 49.17M | 48.88M | 48.6M |
Other Long-Term Liabilities | 69.14M | 73.73M | 54.36M | 89.87M | 79.66M | 90.59M | 91.68M | 82.98M | 69.62M | 70M | 73.3M | 31.55M | 33.5M | 29.1M | 31.1M | 27.4M | 29.33M | -1 | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 217.7M | 219.81M | 222.67M | 235.23M | 224.61M | 299.55M | 281.38M | 272.37M | 258.8M | 257.64M | 258.41M | 216.69M | 217.86M | 176.72M | 125.36M | 121.31M | 122.79M | 49.31M | 49.09M | 49.17M | 48.96M | 48.93M |
Total Liabilities | 678.14M | 659.02M | 601.51M | 595.52M | 566.71M | 543.47M | 511.48M | 468.56M | 445.37M | 401.69M | 397.26M | 331.35M | 332.83M | 277.37M | 221.92M | 181.6M | 165.36M | 73.86M | 72.15M | 73.88M | 71.83M | 70.61M |
Total Debt | 219.21M | 219.9M | 241.3M | 218.6M | 217.31M | 211.23M | 192.96M | 192.3M | 191.8M | 189.43M | 186.37M | 185.58M | 184.71M | 147.72M | 94.68M | 94.33M | 94.17M | 50.28M | 49.71M | 50.05M | 50.05M | 50.12M |
Book Value | 83.3M | 54.59M | 88.3M | 73.73M | 73.08M | 53.21M | 57.02M | 92.9M | 102.85M | 144.04M | 190.98M | 269.51M | 278.8M | 111.81M | 109.56M | 157.36M | 15.2M | 14.7M | 15.63M | 42.72M | 71.44M | 96.29M |
Book Value Per Share | 1.62 | 1.07 | 1.74 | 1.47 | 1.48 | 1.09 | 1.17 | 1.93 | 2.16 | 3.04 | 4.04 | 5.72 | 6.38 | 2.57 | 2.52 | 3.77 | 0.39 | 0.38 | 0.41 | 1.13 | 1.90 | 2.57 |
Common Stock | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4.34K | 3.99K | 3.89K | 3.78K | 3.77K | 3.77K | 3.76K |
Retained Earnings | -1.42B | -1.37B | -1.31B | -1.28B | -1.23B | -1.18B | -1.12B | -1.05B | -983.27M | -903.93M | -835.57M | -736.92M | -674.72M | -607.55M | -596.33M | -535.09M | -490.27M | -448.83M | -409.2M | -375.22M | -340.34M | -308.06M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 83.3M | 54.59M | 88.3M | 73.73M | 73.08M | 53.21M | 57.02M | 92.9M | 102.85M | 144.04M | 190.98M | 269.51M | 278.8M | 111.81M | 109.56M | 157.36M | 15.2M | 14.7M | 15.63M | 42.72M | 71.44M | 96.29M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AXSM